Completed

Lifestyle Heart Trial

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

diet, vegetarianism

+ diet, fat-restricted

+ exercise

Behavioral
Who is being recruted

Arterial Occlusive Diseases+12

+ Arteriosclerosis

+ Hyperlipidemias

From 35 to 75 Years
See all eligibility criteria
How is the trial designed

Prevention Study

Phase 2
Interventional
Study Start: April 1989
See protocol details

Summary

Principal SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Last updated: December 13, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 1989

Actual date on which the first participant was enrolled.

BACKGROUND: The trial was the first randomized, controlled trial to determine whether patients outside a hospital could be motivated to make and sustain comprehensive lifestyle changes and whether coronary disease regression could occur as a result of lifestyle changes alone. DESIGN NARRATIVE: Patients were randomly assigned to an experimental group or to a usual-care group. Experimental-group patients were prescribed a lifestyle program including a low-fat vegetarian diet, moderate aerobic exercise, stress management training, stopping smoking, and group support. No animal products were allowed in the vegetarian diet except egg white and one cup per day of non-fat milk or yogurt. The diet contained approximately 10 percent of calories as fat. Control-group patients were not asked to make lifestyle changes. Coronary angiography was performed at baseline and at one year to assess progression or regression of disease. Patients were recruited into the trial between January 1986 and November 1988. The trial was supported prior to April 1989 from various sources other than the National Heart, Lung, and Blood Institute. Follow-up continued for four years. The study completion date listed in this record was obtained from the Query/View/Report (QVR) System.

NCT00000471
Principal SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Last updated: December 13, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 35 to 75 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Arterial Occlusive DiseasesArteriosclerosisHyperlipidemiasMetabolic DiseasesNutritional and Metabolic DiseasesVascular DiseasesDyslipidemiasLipid Metabolism DisordersCardiovascular DiseasesCoronary Artery DiseaseCoronary DiseaseHeart DiseasesHypercholesterolemiaHypertensionMyocardial Ischemia

Criteria

Men and women, ages 35 to 75, with angiographically documented one, two, or three vessel coronary disease; no myocardial infarction during the preceeding six weeks; and not receiving streptokinase, alteplase, or lipid-lowering drugs.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers